VMD

Y Dược phẩm Vimedimex ·HOSE ·2025Q1

● Maintaining

Pre-tax profit relies materially on non-core sources Net financial result/PBT −2.51%
Price
14,600
Latest close
02 Jun 2026
P/E 8.50x
P/B 0.54x
EPS 1,717
BVPS 27,236
ROE 6.3%
ROA 1.8%
Profit Margin 2.3%
Asset Turnover 0.75x
Equity Mult. 3.56x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2025Q1 basis, VMD has not accelerated revenue, but profitability is improving more visibly — margins have been expanding consistently over multiple periods. Notably, most of the profit comes from non-core sources — this needs careful evaluation before concluding on growth quality.

TTM REVENUE
VND 1,136bn
−59.2%YoY
NET MARGIN
2.29%
+1.6ppYoY
TTM NET PROFIT
VND 26bn
+40.4%YoY
Non-core income / PBT
98.5%
Metric Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23 Q1'23 Q4'22 Q3'22 Q2'22
Revenue 241.3 398.5 237.7 258.2 354.5 591.6 754.3 1,079.9 1,115.7 1,613.0 1,772.3 1,818.9
Growth -39% +68% -8% -27% -40% -22% -30% -3% -31% -9% -3%
Net Income 3.9 14.3 5.3 2.7 2.8 6.7 5.4 3.7 3.9 18.7 9.5 2.5
Net Margin 1.60% 3.58% 2.21% 1.03% 0.78% 1.13% 0.72% 0.34% 0.35% 1.16% 0.53% 0.14%

Drivers of VMD's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by lower selling expenses. Supporting and offsetting drivers:

Selling expenses ↓ 70.9bn
Other profit ↑ 35.8bn
Administrative expenses ↓ 11.5bn
Tax ↓ 2.4bn
Gross profit ↓ 108.3bn
Financial income ↓ 3.4bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by better other profit. Supporting and offsetting drivers:

Other profit ↑ 5.1bn
Finance costs ↓ 1.3bn
Selling expenses ↓ 0.8bn
Financial income ↑ 0.6bn
Gross profit ↓ 5.0bn
Administrative expenses ↑ 1.2bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2024Q1 4.3% = 0.7% × 1.18 × 5.50
2025Q1 6.1% = 2.3% × 0.75 × 3.56

ROE rose from 4.3% to 6.1% — mainly driven by net margin, despite asset turnover and leverage moving in the opposite direction.

Net margin: 2.3% +1.6pp Asset turnover: 0.75x -0.43x Leverage: 3.56x -1.94x

Is the profit sustainable?

Margins improved (+1.6pp), but earnings still rely significantly on non-core sources — warrants closer scrutiny.

very positive positive stable watch under pressure

What is driving the margin?

Net margin expanded to 2.29%, rising 1.6pp. Core operating signals are improving as Gross margin rose 2.1pp are enough to offset pressure from SG&A / Revenue rose 2.9pp (in addition, Other profit / Revenue rose 3.0pp added support while Net financial result / Revenue fell 0.2pp remained a drag).

Most of the margin increase comes from non-core items — core operations have not kept pace, this is a margin expansion to watch carefully.

Profitability trend

Net Margin 2.29% +1.6pp
Gross Margin 10.06% +2.1pp
SG&A / Revenue 9.94% +2.9pp
Non-core / Revenue 2.86% +2.8pp

TTM YoY · 2024Q1 -> 2025Q1

Watchpoints

Other income is supporting margin

Other income accounts for 98.5% of PBT and lifted net margin by 2.8pp — separate the operating contribution from this source.

Is capital being used efficiently?

Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.

Is capital being deployed efficiently?

Track how much operating profit the business generates on invested capital.

Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.

CAPITAL EFFICIENCY TREND

TTM YoY · 2024Q1 -> 2025Q1

ROIC
NOPAT Margin 0.03% −0.7pp
Capital Turnover
Average Invested Capital

Balance Sheet

ROIC above should be read with industry context — the balance sheet below adds perspective. Balance sheet is exceptionally sound — liabilities at 1.87x equity, with a net cash position equivalent to 0.32x equity.

Over the last 12 months, working capital released 167.7bn of cash, mainly thanks to lower receivables and lower inventories. Pressure from lower payables only partly offset that benefit.

Working Capital Drivers

TTM YoY · 2024Q1 -> 2025Q1

Receivables decreased → higher CFO: +208.9bn
Inventories decreased → higher CFO: +103.1bn
Payables decreased → lower CFO: −144.4bn

Working Capital Efficiency

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 37.5 days versus the same period last year. The main moves came from DIO fell 4.0 days, DSO rose 50.4 days, and DPO rose 83.9 days.

Extended payment timing is the main driver — consider whether this trades off supplier relationships.

Watchpoints

Receivables collection is slowing

DSO increased by +50.4 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2024Q1 -> 2025Q1

Receivables 168.9 days +50.4 days
Inventory 78.4 days −4.0 days
Payables 267.2 days +83.9 days
Cash Conversion Cycle -19.9 days −37.5 days

Is financial risk significant?

Financial risk is low — the company has net cash and CFO reached 118.7bn.

Leverage & Liquidity

Leverage warrants monitoring, with net debt / equity at -0.32x and interest coverage only at 0.06x.

Debt maturity and the cash buffer remain the two key areas to monitor.

Some leverage signals are missing, so the current read should be treated as contextual.

Watchpoints

Interest coverage is thin

Interest coverage is 0.06x, leaving limited room to absorb financing costs.

Leverage and liquidity trend

Net Debt / Equity -0.32x −0.10x
Interest Coverage 0.06x −4.10x
Cash / Debt
Short-term Debt / Total Debt
CFO / NI 8.02x +10.82x

TTM YoY · 2024Q1 -> 2025Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 118.7bn in 2024, against investing cash flow of 4.1bn.

Post-investment cash flow was positive +122.8bn. Financing cash flow was negative +31.4bn.

CFO / net income was 8.02x.

After spending +2.7bn on fixed-asset investment, the business generated trailing free cash flow of +210.0bn.

Cash Conversion

TTM Cash Conversion · 2024Q1 -> 2025Q1

CFO TTM 212.7bn +266.7bn
Cash Capex 2.7bn −10.0bn
FCF TTM +210.0bn +276.7bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 1.6 pp. The next item to monitor is the earnings mix, when non-core contribution is -2.5%. The main risk still sits in leverage and liquidity, with interest coverage at 0.06x.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 2.29% after expanding 1.6pp versus the same period last year.

Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 8.02x. Even so, net financial result still accounts for -2.5% of PBT, so the earnings mix still needs monitoring.

Key risk: leverage and liquidity still require discipline, with interest coverage only at 0.06x.

Statement Data

Item 2024 2023 2022 2021 2020
Net Revenue
1,249.9 3,544.0 7,073.5 12,318.8 18,162.2
Cost of Goods Sold
1,130.9 3,255.8 6,528.7 0.0 0.0
Gross Profit
118.9 288.2 544.8 1,068.7 1,396.3
Financial Expenses
10.3 4.8 23.6 -174.5 -188.1
Selling Expenses
85.7 207.1 444.4 -826.1 -1,117.8
General and Administrative Expenses
27.7 43.1 68.2 -90.1 -92.2
Operating Profit
2.6 46.6 46.5 26.5 41.3
Profit Before Tax
30.6 43.6 47.4 28.2 50.4
Net Income
23.6 31.2 35.2 19.1 37.1
Profit Attributable to Parent
23.2 28.2 34.8 19.8 37.1
Earnings per Share
1,449.00 1,737.00 2,255.00 -525.00 2,400.76

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.